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Cumulative Dissertation, Introductory Summary  
Abstract 
 
Background: Evidence suggests increasing prevalence of type 2 diabetes (T2D) in 
Bangladesh, imposing huge social and economic impacts. Mobile phone SMS have the 
potential to improve diabetes outcome. The research aimed to measure the clinical status and 
complications of T2D, mobile phone use and willingness-to-pay for diabetes SMS, effects of 
SMS on glycemic control, and healthcare use and expenditure for diabetes in Bangladesh.  
Methods: We conducted a cross-sectional study among 515 patients with T2D in a tertiary 
hospital in Dhaka and selected 236 patients meeting the eligibility criteria for a randomized-
controlled trial of an SMS intervention. We further conducted a matched case-control study 
including 591 additional individuals with diagnosed diabetes and 591 age, sex and residence 
matched controls without diabetes at the same hospital.  
Results: The majority of patients with T2D had uncontrolled diabetes (71.3%) and self-
reported complications (91.5%). In the randomized trial, the SMS intervention was effective 
with respect to the primary endpoint. Among the trial participants, the least squares mean 
difference of HbA1c from baseline to after 6 months was -0.85 (-1.05, -0.64) in the SMS 
group and -0.18 (-0.41, 0.04) in the control group. The difference between means was -0.66 (-
0.97, -0.35; p<0.0001). In the case-control study, patients with diabetes had two times more 
days of inpatient treatment, 1.3 times more outpatient visits, and 9.7 times more medications 
than those without diabetes (all p<0.005). The total annual per-capita healthcare expenditure 
was 6.12 times higher for persons with diabetes than non-diabetics (USD 635 vs. 104, 
respectively).  
Conclusion: This research provides evidence that diabetes management in Bangladesh is 
suboptimal even under best clinical settings and costly. It also demonstrates the effectiveness 
of an innovative automated SMS service as an addition to standard care in the management of 
T2D. As the mobile phone SMS setup is scalable and low-cost, it may be considered for 
diabetes care in Bangladesh and similar developing countries. 
 
Key Words: Type 2 diabetes (T2D); Short Message Services (SMS); medication adherence; 
glycemic control; willingness to pay (WTP); health care use and expenditure; depression 
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Abbreviations 
 
BDT: Bangladesh Taka 
BIHS: Bangladesh Institute of Health Science 
BIRDEM: Bangladesh Institute of Research on Diabetes, Endocrine and Metabolism 
BMI: Body Mass Index 
BP: Blood Pressure CI: Confidence Interval 
CI: Confidence Intervals 
CVM: Contigent Valuation Method 
CKD: Chronic Kidney Diseases  
CVD: Cardiovascular Diseases 
DM: Diabetes Mellitus 
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HbA1c: Haemoglobin A1c or Glycated Haemoglobin 
ICDDR,B: International Center for Diarrhoeal Diseases Research, Bangladesh 
IDF: International Diabetes Federation 
IQR: Intra-Quartile Range 
LMU: Ludwig-Maximillians Universitat 
LMICs: Low and Middle Income Countries 
mHealth: Mobile Health (Mobile Phone Based Health Service) 
NCDs: Non-Communicable Diseases 
Non-DMS: Persons without Diabetes 
OPD: Out Patient Department 
SBP: Systolic Blood Pressure 
SMS: Short Message Service 
SPSS: Statistical Packages For Social Sciences 
T2D: Type 2 Diabetes 
WHO: World Health Organization 
WTP: Willingness to Pay 
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1. Introduction 
1.1) Global epidemiology of NCDs and diabetes 
In recent years, non-communicable diseases (NCDs) such as diabetes, cardiovascular diseases, 
respiratory disease and cancers have increased in epidemic proportions globally. Around 80% 
of deaths due to NCDs occur in low-and-middle-income countries (LMICs), where the health 
systems are inadequate to provide the essential services [1]. The epidemiological transition 
and double burden of diseases in developing countries might be resulting from increasing age 
of the population, increase in average lifespan, decrease in childhood infections and death, 
rural-urban migration, and adoption of unhealthy lifestyle such as sedentary work habits, diets 
rich in fats, carbohydrate, and salt among others [1]. Diabetes is one of the leading causes of 
morbidity and mortality, affecting more than 382 million people globally and is projected to 
double by 2030 [2]. The global burden of disease study reported that over the last two decades 
NCDs have substantially increased in terms of absolute number of years of life lost and years 
lived with disability, and diabetes contributing to the largest increase in diseases burden [3].  
 
1.2)  Epidemiology of diabetes in Southeast Asia  
Almost one-fifth of the world's total population with diabetes live in Southeast Asia region, 
where the prevalence of diabetes is estimated to increase by 71% by 2035 [2]. The 
International Diabetes Federation (IDF) Diabetes Atlas indicates that by 2030, 10.2% of the 
adult population in this region will have diabetes increasing the number of people with 
diabetes to 120.9 million [4]. Rapid urbanization and economic growth in many countries of 
Southeast Asia have lead to exposure to new risk factors, such as adverse dietary pattern, 
sedentary lifestyles, obesity, environmental exposure among others in addition to traditional 
risk factors of increasing age and genetic predisposition [5]. Southeast Asians develop type 2 
diabetes at a lower body mass index (BMI) compared to Caucasians and have more central 
obesity [6]. Moreover, diabetes and its complications also develop at a relative younger age in  
South Asians compared to the Western population [7-9]. 
 
1.3)  Epidemiology of type 2 diabetes in Bangladesh  
According to the IDF Diabetes Atlas, there are an estimated 8.4 million people with diabetes 
in Bangladesh and a similar number of people with prediabetes. The IDF projected that the 
number of people with diabetes will increase to 16.8 million by 2030, placing Bangladesh 
among the top ten countries globally in terms of number of people living with diabetes [2]. A 
recent population-based study reported the overall age-adjusted prevalence of diabetes 15.2% 
in urban areas compared with 8.3% in rural areas in Bangladesh [10]. A scoping review of the 
increasing trend of diabetes prevalence in Bangladesh showed that the prevalence of diabetes 
varied from 4.5% to 35% with a pooled prevalence of 7.4% (95% CI 7.17-7.63) [11].  This 
study reported the increasing prevalence of diabetes in the urban and rural population at rate 
of 0.05% and 0.06% per year respectively in Bangladesh. Another systematic review of the 
risk factors for diabetes in Bangladesh identified the most common risk factors for diabetes in 
Bangladesh, namely increased age, obesity, social class, hypertension, family history, 
sedentary life style among others, which differed by urban-rural areas and by gender [12]. 
Diabetes is a complex condition and impacts on individuals, families, societies, health 
systems and the nation as a whole. The economic and human costs provoked by diabetes in a 
large population such as in Bangladesh will be substantial [13]. However, the social and 
economic impact of diabetes in Bangladesh, as well as its impact on individual, society and 
health systems level is largely not known.   
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1.4) Roles of mHealth in the management of type 2 diabetes 
The growing epidemic of diabetes in Bangladesh and other developing countries suggest that 
traditional methods for diabetes management in hospital settings or clinics, might not be 
adequate to control the epidemic alone. Globally, mobile phone technologies have emerged as 
an essential tool for strengthening health systems and improving disease management in many 
countries [14]. In recent years, the Government of Bangladesh and the World Health 
Organization (WHO) have adopted information technologies for health to their strategic plans 
[15]. Previous studies showed the effectiveness of SMS for increasing medication adherence 
and behavior changes in developing countries [16-18]. Substantial evidence suggest that 
mobile phones might be a potential tool for addressing NCDs requiring life-long treatment in 
developing country settings [19, 20]. However, such innovative technologies for health 
interventions are complex and require solid evidence before they could be scaled up.   
 
2. Rationale and Objective 
A. The cross-sectional study: Substantial evidence suggests that in patients with type 2 
diabetes (T2D) in Southeast Asian countries,  diabetes starts relatively earlier in life and 
patients report higher number of complications as compared to Western populations. However, 
to the best of our knowledge, factors determining the clinical status and complications of 
patients with diabetes in Bangladesh have not been studied in detail. We therefore conducted 
this cross-sectional study in patients with T2D on oral therapy and with a time since diagnosis 
of less than 10 years to assess the current clinical status and complications. The results of this 
study will help clinicians and policy makers to further develop management plans for diabetes 
in Bangladesh and other developing countries. 
 
B1. The Mobile phone use and Willingness to pay (WTP) for diabetes SMS study: 
During the last decades, there has been a dramatic increase in mobile phone penetration rates 
in Bangladesh, reaching all segments of the population [21, 22]. However, the use of mobile 
phones by patients with T2D and their willingness to pay for a diabetes SMS services are 
largely unknown. The objective of this study was to assess the mobile phone use and 
willingness to pay for a diabetes SMS service.  
 
B2. The SMS intervention trial: Data to support a successful model of mobile phone SMS 
in disease management in Bangladesh are not available. In this trial, we therefore assessed 
whether the addition of an automated mobile phone SMS service to standard diabetes care 
would improve glycemic control in patients with type 2 diabetes in Dhaka city. If this 
intervention proves to be efficient and cost-effective in our trial, large-scale implementation 
of this care model could be undertaken for diabetes and, possibly for other NCDs in 
Bangladesh and potentially other countries. 
 
C. The case-control study: Information on the availability, cost, and quality of medical care 
for diabetes is mostly not available for many low-and-middle-income countries, including 
Bangladesh. Complications from diabetes, which can be devastating, could largely be 
prevented by wider use of several inexpensive generic medicines, simple tests and monitoring 
and can be a cost saving intervention. There is a need for information on healthcare use and 
expenditure for diabetes to develop strategies and policies in Bangladesh. In this context, we 
conducted the first-ever comprehensive case–control study to measure the healthcare use and 
expenditure for diabetes in Bangladesh. This study will provide an in-depth and 
comprehensive picture of social and economic impacts of diabetes in Bangladesh and propose 
clear recommendations for improving prevention and management of diabetes.  
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3. Methods  
 
A. The cross-sectional study: 
Study population and settings: We conducted a cross-sectional study among 515 patients 
with T2D attending the outpatient department (OPD) of Bangladesh Institute of Health 
Science (BIHS) hospital in Dhaka from September to December 2013. The BIHS is a tertiary 
hospital of the Diabetes Association of Bangladesh. All registered patients with T2D are 
attended by certified diabetologists, receive a session of health education during registration 
and are referred to appropriate specialist at BIHS as necessary.  
 
Data collection process:  We collected data through face-to-face interviews using structured 
questionnaires, physical measurements, laboratory investigations and review of medical 
records. We obtained written informed consent from each participant. The ethical review 
committee of icddr,b approved the research protocol (PR#13068). The variables, 
measurements and case definitions are provided in details in the study protocol [23].  
 
Statistical analysis: Data analyses were performed using SPSS version 20 (SPSS 
Corporation Inc., IL, USA). Data were expressed as mean ±SD and for non-normal data were 
as Median (IQR). Frequencies and percentages for independent variable were calculated. In 
simple logistic analysis, each independent variable was analyzed to look at any significant 
association with dependent variable (diabetes complications). The findings were presented 
with adjusted OR, its 95% CI and corresponding P-value. The level of significance was set at 
0.05. 
 
B1.Mobile phone use and WTP for diabetes SMS : 
We conducted a WTP study as part of the randomized controlled trial on mobile phone SMS 
intervention. WTP was defined as the monthly amount of money each participant would be 
willing to pay if an SMS service for diabetes was available, in addition to regular medical care. 
We used contingent valuation methodology (CVM) to quantitatively measure patient WTP.  
 
B2. The SMS intervention trial: 
Study site and population: This was a six month, prospective, parallel-group, randomized 
controlled single-centre clinical trial designed to evaluate the effectiveness of mobile phone 
SMS in addition to standard care compared with standard care alone for glycemic control 
among patients with type 2 diabetes. The study protocol has been reported previously [24]. In 
brief, patients with type 2 diabetes (diagnosed within the last 5 years) attending the OPD of 
BIHS hospital in Dhaka, Bangladesh were recruited for this study between September 2013 
and August 2014.  
 
Patients were eligible for the study participation if they were over 18 years old, diagnosed as 
T2D  patients by the BIHS attending physician according to WHO criteria, [24, 25] registered 
with the BIHS, taking oral antidiabetic medication, able to access a mobile phone on a daily 
basis and able to read SMS. Patients with insulin therapy, type 1 diabetes, gestational diabetes, 
other serious illness or co-morbidities requiring hospitalization, living outside Dhaka city and 
not having access to a mobile phone were excluded. The study protocol (PR#13068) was 
approved by the Research Review Committee and Ethical Review Committee of the ICDDR, 
B and received an Ethical Committee waiver from LMU and BIHS. This trial is registered in 
the German Clinical Trial Registry drks.de, DRKS00005188.  (Annex-3: Trial Profile) 
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Randomization and masking: Of the 515 patients, 236 patients meeting the selection criteria 
were randomly assigned (1:1) by simple randomization to the SMS intervention plus standard 
of-care or standard-of-care alone (control group). The principal investigator generated the 
randomization numbers using a random number generating program (GraphPad Software, Inc., 
California, USA). Laboratory personnel and the principal and co-investigators were masked to 
the participants' group allocation until the end of the study. However, clinic staff and 
participants could not be masked because the intervention required active overt participation.  
 
Procedures: All consecutive newly diagnosed patients with type 2 diabetes on oral 
medication were referred by the BIHS attending physician for the study. After screening for 
eligibility and obtaining written informed consent, data were collected through face-to-face 
interviews using a structured questionnaire, anthropometric measurements of weight, height, 
hip circumference, waist circumference, blood pressure, pulse and blood tests for HbA1c 
using standard procedures as mentioned in the study protocol [24]. Diabetes was diagnosed by 
BIHS attending physician according to WHO guidelines [25] and was validated by the study 
physician during recruitment through review of clinical and investigation records. Medication 
adherence was measured using Morisky 8-Item Medication Adherence Scale (MMAS) [26].  
 
The SMS were developed by a team comprising of two general medical practitioners, an 
endocrinologist, two epidemiologists, a nurses and two undergraduate students. After 
developing the SMS in Bengali, we sent the SMS to several individuals in the pre-test stage 
including persons who can only read SMS and have no formal education qualifications. After 
receiving the feedback, we adopted the contents of the SMS for the general population. We 
ensured that all our participants in the study could read the SMS by themselves or someone in 
the family could read the messages to them. Most of the 90 SMS were developed based on the 
principles of behavioral learning theory and trans-theoretical model of behavioral change [27, 
28]. All participants in the SMS intervention group received the 90 SMS randomly, once a 
day over a six month period. Some examples of the SMS are available in the study protocol 
published previously [24]. A SMS delivery manager website was created and SMS delivered 
in partnership with Telenor based Grameenphone Bangladesh.  
 
The data collection team comprised of a physician, a research officer and three research 
assistants who were supervised by the principal investigator. The team was trained for two 
weeks by senior scientists and researchers at the Center for Control of Chronic Diseases, 
icddr,b on the study protocol, diabetes epidemiology, anthropometric measurements, research 
ethics and interview skills. All data were prospectively recorded on case report forms, which 
were forwarded to the study coordination center in icddr,b for data entry and analysis. Data 
that were missing, inconsistent, or both were obtained or clarified by direct communication of 
the data collectors. Data were unmasked when the six month clinical follow-up information 
from all patients had been obtained. All data were held at the study coordinating centre, but 
the principal investigator had full access to them. 
 
Sample size: We based the sample size calculation on the hypothesis that the mobile phone 
SMS intervention is superior to standard care in reducing HbA1c by 0.5 points [29, 30]. 
Assuming a standard deviation of 1 and an alpha error level of 5%, the two-tailed calculation 
provided a power of over 90% with 90 participants in each arm of the study. To allow for a 
20 % dropout rate, a total of 226 participants were required for the study. 
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Statistical analysis: We compared the baseline characteristics between the study groups with 
Chi-Square, Fisher’s Exact, Mann Whitney-U test and t-tests. To test the primary hypothesis 
we used an intention to treat analysis based on all study participants with any follow-up 
information available. In accordance with the ICH E9 guideline [31], a total 36 participants 
with no data post randomization were excluded from the analysis. We calculated the least 
squares means of the HbA1c change between baseline and 6 month for the intervention and 
the control group and the difference between the two least square means using the SAS 
generalized linear model procedure. The same procedure was used to compare the two least 
squares means and to compute 95% confidence intervals (CIs). Baseline HbA1c, patient age, 
sex, education level, duration of known diabetes and the number of diabetes-related 
complications were included in the model to adjust for potential heterogeneities in the 
composition of the two study groups. The criterion for significance was set at α=0.05. The 
same method was used for the post-hoc subgroup analysis. Data were analyzed using SAS 
version 9.3 (SAS Institute Inc, NC, USA) and SPSS version 20 (IBM, New York, NY, USA). 
 
C. The case-control study:  
Study site and population: We conducted a matched, case-control study including 591 
persons with diagnosed diabetes (DMs) and 591 age, sex and residence matched controls 
without diabetes (non-DMs) at the OPD of BIHS hospital between January and July 2014. 
Detailed methodology of the study design has been published elsewhere [13].  
 
Sample size and selection: We considered a sample size of 500 cases and 500 controls to 
provide 90% power to detect a 5 percent difference in rates and proportions between cases 
and controls. Inclusion criteria for cases were: adults diagnosed with diabetes at BIHS OPD 
according to WHO criteria, provision of anthropometric measurements, and written informed 
consent.  Controls were individuals without a self-reported history of diabetes matched on a 
1:1 basis to cases by area of residence, age (within a 5 year band), and sex (male or female). 
We included all consecutive patients meeting the inclusion criteria waiting for consultation at 
the BIHS OPD. Controls were recruited within 48-hours of recruiting the index case, from 
either visitors of patients attending the OPD, or non-blood related visitors of index diabetes 
cases, in the same hospitals or the same geographical residence of cases. All controls 
underwent identical study questioning and examination as cases. One completed control 
interview was obtained for each case interview. (Annex-4. Selection of participants) 
 
Data collection: The research tools and instruments used in this study were developed by the 
IDF Health Economic Group and translated into Bengali according to the WHO process of 
translation and adaptation of research instruments [32]. The questionnaires were field tested in 
a similar setting at the OPD of BIRDEM hospital before conducting the interviews among 25 
cases and 25 control subjects. Feedback from the field tests was used to improve the language 
and the contents of the questionnaire and tools, as well as adapt them to local circumstances 
based on previous validated survey items [4]. Detailed methodology of data collection, 
including the questionnaire, variables, definitions and methods are published in the study 
protocol [13].  
 
Ethics: The study was approved by the Research Review Committee and Ethical Review 
Committee of the International Center for Diarrheal Diseases Research, Bangladesh (PR-
13062) and obtained ethical clearance waiver from Ludwig-Maximilians-Universität (LMU) 
and BIHS. 
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Data analysis: Descriptive analysis was performed for all variables and unadjusted 
comparisons between case and control were performed using t-tests (for continuous variables) 
or chi-square tests (for discrete variables). We estimated the impact of diabetes on healthcare 
use by calculating ratios and difference between DMs and non-DMs and tested for statistical 
difference using t-tests. All statistical analyses were performed using SPSS version 20 (IBM 
Corporation, USA).  
 
4. Results 
A. Socio-demographic and clinical characteristics of the study participants: A total of 
515 patients participated in this study with a mean±SD age of 50.0±10.1 years and 55.9% 
were females. Majority of the participants were married (87.2%), completed secondary and 
higher level of education (71.5%) and had a family history of diabetes (68%).  The median 
(IQR) income was 30 (34) thousands Bangladesh Taka (BDT). The median (IQR) time since 
diagnosis was 3 (6) years. The median (IQR) duration of hypertension was 5 (8) years. 
Almost 58% of the participants had diagnosed hypertension, 45% overweight and 18% obese 
according to BMI, 73% increased waist circumference and 97% high waist hip ratio.  The 
mean HbA1c was 8.3±2.1%. The overall prevalence of dyslipidemia was 72.7%.  
 
Complications: Among the 515 patients, only 44 (9.5%) reported no known complications. 
Most of the patients, had eye complications (68.9%), which was followed by chronic kidney 
disease (21.3%), cardiovascular diseases (11.8%), neurological problems (2.7%). About one 
third patients reported other chronic diseases such as bronchial asthma, tuberculosis, arthritis. 
We considered chronic kidney diseases according to eGFR. Other complications were 
recorded from patient’s self-reported questionnaire and medical records. Eye complications 
were reported very frequently but funduscopy results were only rarely available. Therefore 
eye problems likely in many instances were unrelated to diabetes. There were significant 
associations between the complications and age, duration of diabetes and duration of 
hypertension in the univariate models. In the multivariate analyses, adjusting for other 
confounding variables, only SBP was significantly associated with complications [OR 0.809, 
95% CI 0.666–0.981, p-value 0.031]. 
 
B1. Mobile phone use: All participants in this study owned a mobile phone. About half of the 
participants reported to be able to read/retrieve. SMS, while only 36.1% could send SMS. The 
median (IQR) years of mobile phone use among participants was 7 (6) years, which was 
significantly higher among males. A greater number of participants reported to read or send 
one SMS monthly (46.6%) and very occasionally (36.5%) than those who read or sent SMS 
more frequently. Half of the participants never read any SMS, one-fifth occasionally read and 
about one-third reported to read all SMS or only from known people. The use of SMS was 
significantly higher among males (P<0.001). The median (IQR) amount spent in a month for 
mobile bills was 300 (600) BDT. Males also reported spending significantly more on mobile 
phone bills compared with females. All participants in the study, except two females, reported 
their interest in receiving SMS for diabetes.  
 
Willingness to pay (WTP) for diabetes SMS: Of the 515 participants, 268 (52.0%) 
expressed a positive WTP, 84 (16.3%) expressed a Zero WTP and 163 (31.6%) did not know 
how much to express or did not answer (missing). This left us with 352 (68.3%) for analysis 
of WTP. The median (IQR) WTP for SMS for diabetes in a month was 20 (45) BDT. The 
median WTP was around 36% of participants’ monthly physician fees, 10% of mobile bill, 8% 
diabetic food costs and 3% of total monthly medication costs. In the multivariate analysis, 
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controlling for all other factors, WTP was significantly higher among males [OR 2.4, 95% CI 
(1.0–5.7)], those with household income. 50 000 BDT [4.6 (1.1–20.4)] and among those with 
primary education [5.6 (1.2–26.6)], secondary and higher education [5.2 (1.4–19.6)].  
 
B2. Effects of SMS for glycemic control: The demographics and baseline characteristics of 
the study groups were generally well balanced, and similar to the general diabetic population 
in Bangladesh [10]. The mean±SD age of the participants was 48.1± 9.7 years, and 54.2% 
were females. The majority of the participants were married (89.4%), completed secondary 
education (70.3%) and had a family history of diabetes (65.7%). The median (Q1,Q3) 
duration of diabetes was 1 (0, 3) years. The mean±SD HbA1c at baseline was 8.4±2.6 % 
(68±28.4 mmol/mol).  
 
Table 1. Difference in HbA1c (%) between baseline and 6 months 
Primary outcome Least squares mean (95% CI) p-value 
SMS group (n=106) -0.85 (-1.05, -0.64)  
Control group (n=94) -0.18 (-0.41, 0.04)  
Difference between means (95% CI) -0.66 (-0.97, -0.35) <0.0001 
 
Table 1 shows the difference in HbA1c between baseline and 6 months. In a secondary 
analysis, the mean medication adherence score decreased significantly in both the SMS and 
the control group, indicating greater self-reported adherence to medication over time. There 
was no significant difference between the groups. Post-hoc subgroup analyses suggested that 
the SMS intervention worked better in females, those with a baseline HbA1c >8%, and those 
with a shorter duration of diabetes. (Annex-4: Results of post-hoc the sub-group analysis) 
 
C1. The case-control study for healthcare use and expenditure for diabetes: Patients with 
diabetes had two times more days of inpatient treatment, 1.3 times more outpatient visits, and 
9.7 times more medications than those without diabetes (all p<0.005). The total annual per 
capita expenditure on medical care was 6.12 times higher for persons with diabetes than non-
diabetics (USD 635 vs. 104, respectively). Among persons with diabetes, 9.8% reported not 
taking any antidiabetic medications, 46.4% took metformin, 38.7% sulphonylurea, 40.8% 
insulin, 38.7% any antihypertensive medication, and 14.2% took anti-lipids over the 
preceding 3 months. 
 
C2. Association between diabetes and depression: Further analysis of the case-control 
study showed that the prevalence of depression was 45.2% and 19.8% among persons with 
diabetes and persons without diabetes, respectively. In the multivariate analysis, mild as well 
as moderate to severe depression were significantly associated with diabetes and independent 
of sociodemographic factors and the number of diabetes-related complications (adjusted OR= 
2.0, 95% CI= 1.4-2.9 and adjusted OR= 6.4, 95% CI= 3.4-12.3; with p=<0.001 for both).   
 
5. Discussion 
A. Clinical status and complications of diabetes: The majority of the 515 participants with 
T2D reported uncontrolled diabetes (71.3%) and self-reported chronic complications (91.5%). 
The prevalence of hypertension and dyslipidemia was 57.5% and 72.7%, respectively. Our 
results show that a great proportion of patients diagnosed with T2D in Bangladesh are 
relatively young and have a higher proportion of complications at diagnosis, compared to 
Western population. Central obesity was a common feature among most participants and 
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higher in females. The high rates of obesity along with unhealthy diet and lack of physical 
activity might lead to insulin resistance, beta cell dysfunction causing uncontrolled diabetes in 
this population. The findings suggest poor glycemic control and suboptimal diabetes 
management, which does not sufficiently reach the patients. Measures to improve clinic 
attendance, medication adherence, awareness and ability to manage diabetes are needed. In 
this study, eye problems were the most frequent complication followed by CVD, CKD, 
neurological problems and others. 
 
Our study provides evidence that diabetes management in Bangladesh is suboptimal even 
under best clinical settings which might be similar in other areas of Bangladesh and many 
developing countries. As majority of patients in this study are relatively new cases of T2D 
presenting with high rates of complications, we can expect that for patients with longer 
duration, the number of complications will be much higher. Also it is expected that time of 
diagnosis is late and the T2D has probably been ongoing for years before it was diagnosed. 
Therefore a better screening for diabetes is necessary in Bangladesh. For prevention of 
complications, based on our data, there is a need for improving HbA1c, lowering BP and 
probably adding a statin to lower LDL cholesterol. 
 
B1. Mobile phone use and WTP: This study, to the best of our knowledge, represents the 
first attempt to investigate the WTP for SMS-based service for any chronic, non-
communicable diseases in Bangladesh. In this study, except for two participants, all expressed 
willingness to receive diabetes-related SMS and the median (IQR) WTP was 20 (45) BDT per 
month, which seems reasonable for such services compared with the current expenditure for 
physician fees. Results of this study demonstrate that a great majority of individuals with type 
2 diabetes in an urban area of Bangladesh are willing to receive SMS for diabetes and to pay a 
small amount for such a service. Considering the huge number of diabetes patients and the 
low mobile phone rates in Bangladesh, a self-sustained business model for basic mHealth 
services for chronic diseases is therefore feasible in this and potentially other low-income 
countries. 
 
B2. Effects of the SMS intervention: This study is the first in the developing countries, to 
the best of our knowledge, to measure the effectiveness of mobile phone SMS for glycemic 
control and medication adherence in patients with type 2 diabetes in clinical settings. Patients 
who received the additional SMS support were more likely to report higher adherence to 
diabetes medication and were more likely to have their blood glucose levels controlled 
compared to patients who received standard of care alone. Our primary analysis showed that 
the overall effect of mobile phone SMS was superior to standard-of-care alone in reducing 
HbA1c among newly diagnosed patients with type 2 diabetes in Bangladesh which support 
our primary hypothesis and was statistically significant. Our reported changes in HbA1c after 
6 months intervention seem to be lower than reports other studies [33]. Results of the sub-
group analyses showed that SMS intervention worked better in females and those with a 
higher HbA1c at baseline. Our finding is consistent with a previous systematic review, 
suggesting the benefit of individual education on glycemic control compared with the usual 
care in those patients with a baseline HbA1c >8% [34]. The design of SMS intervention and 
the objective measurement of HbA1c allowed us to isolate potential effects of the SMS 
intervention from other aspects of general practice care for patients with type 2 diabetes in the 
clinics.  
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This study demonstrates the effectiveness of an innovative model of care in the management 
of type 2 diabetes in Bangladesh. As mobile phone SMS is potentially scalable and likely to 
be low-cost, it might be considered as an additional technique for glycemic control in the 
clinics for patients with type 2 diabetes in Bangladesh and similar other developing countries. 
Further studies on potential benefits of SMS on cardiovascular risks factors, diabetes 
complications, physical activity and dietary adherence should be explored.  
 
C1. Healthcare use and expenditure for diabetes: This study highlights the large economic 
burden of diabetes on individuals and healthcare systems in Bangladesh. To the best of our 
knowledge, this study is the first-ever published matched case-control study of healthcare use 
and expenditure for diabetes in South Asia. Our results show that the use of healthcare 
services and medicines was dramatically higher among persons with diabetes (DMs) than in 
matched controls without diabetes. DMs reported twice as many inpatient admissions and 
annual inpatient treatment days, 1.33 times more annual outpatient visits and 9.7 times more 
prescription medicines compared to non-DMs. Using the IDF estimates of 8.4 million DMs in 
Bangladesh, the total estimated healthcare expenditure for diabetes in Bangladesh is around 
5.3 billion USD.  
 
A greater number of patients with diabetes presenting at the clinics in Bangladesh have 
uncontrolled diabetes and underuse antihypertensive drugs and statins, as found in our 
previous study [7], which might result in expensive, disabling complications and higher use of 
medical service as found in this study.  In Bangladesh, as in most developing countries, 
barriers to public-health facilities force the poor to pay for healthcare out-of-pocket, often 
driving them further into poverty [35, 36].  As a result, DMs may not seek required preventive 
care, which further increases the risk of complications and are more costly (if treated at all). 
This underuse of medical care by the general population is a third driver of the large diabetes-
associated differences that we report. Medical care in Bangladesh is very costly relative to an 
average person's mean family income, often difficult to access, and leave a household 
vulnerable to the effects of catastrophic health expenses [35-37]. Bangladesh has an 
opportunity to reduce future healthcare costs by diagnosing diabetes earlier and by using 
inexpensive generic medicines much more widely and thus reducing hospitalizations, 
disability, mortality [38, 39]. Our data suggests that DMs in Bangladesh are less likely to 
receive preventive services and medication for proper management of diabetes and its 
complications, and therefore their high use of inpatient services might be the unfortunate 
result. 
 
We estimated that healthcare expenditure were 6.12 times higher among DMs than among non-
DMs. A similar study in China showed point-of-service payments was 3.97 times higher 
among DMs than Non-DMs [40]. The expenditure for diabetes in Bangladesh was much 
higher compared to China and other developed countries where the ratio of expenditure for 
diabetes ranged from 2.0-2.5 [41-43]. Thus, the social and economic impact of diabetes might 
be much higher in developing countries like Bangladesh compared to developed countries 
[40]. The IDF estimated the healthcare costs attributed by diabetes in developing countries to 
be USD 356 in 2013[44]. If the adjusted expenditure ratio of 6.12 that we observed had 
instead been used, the IDF estimate would have been much higher. The expenditure ratios 
reported here imply, that in Bangladesh the economic burden of diabetes may constrain the 
availability of medical resources for other health conditions and impede national economic 
growth in future.  
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C2. Association between diabetes and depression: This study, to the best of our knowledge, 
is also the first matched case-control study measuring the prevalence of depression and its 
association with diabetes. Our study showed that depression, particularly in a moderate to 
severe form, is more common in patients with diabetes than those without diabetes. In 
addition, we found that the association of depression and diabetes is independent of 
sociodemographic factors and diabetes-associated complications. Therefore, patients with 
diabetes should be routinely screened for depression in Bangladesh and probably in other 
developing countries as well. Management strategies and guidelines adequate for the country 
level need to be developed and further research to determine the pathophysiological role of 
depression in the development of diabetes in Southeast Asians is merited. 
 
Limitations of the studies: Our study had several limitations. First, in the cross-sectional 
study,   we collected data from the outpatient of a single hospital in Dhaka city among 
relatively new cases with access to mobile phones and on oral medications only. Thus, the 
results cannot be generalized to all diabetes patients in Bangladesh. Second, most of the 
complications were self-reported and based on patients medical records, which cannot be 
verified. Therefore, our reported complications might be higher and not always related to 
diabetes. Second, the WTP study was conducted among the participants of a trial, and thus 
WTP might be different from the general diabetes population in Bangladesh. Third,  
our RCT was open-label design, as blinding participants was not possible due to the nature of 
the intervention. Because no post-randomization data were available for the study participants 
lost to follow-up, we did not do a full intention-to-treat analysis with imputation of missing 
values. However, the proportion of lost subjects was small and most likely did not affect the 
primary outcome. The study population was representative of the general diabetic population 
in Bangladesh [10], but since access to a mobile phone was required generalizing the results 
to rural areas or even poorer parts of society may not be possible. Similarly, it remains to be 
determined whether the HbA1c-lowering effect of the intervention persists for periods longer 
than six months. Fourth, for the case-control study, we excluded undiagnosed cases of 
diabetes and pre-diabetes, therefore the results might overestimate medical services utilization 
for persons with undiagnosed diabetes and prediabetes. It is likely that DMs in our samples 
were mostly from urban areas, had more complications and were more likely to use and to be 
able to afford healthcare services than the general diabetes population. Fifth, a major 
limitation of this study is recall bias by cases and controls about different costs associated 
with disease and hospitalization. Finally, due to time constraints, we were not able to perform 
the socio-economic status (SES) analysis for diabetes and the cost-effectiveness analysis of 
the effectiveness of the SMS intervention for this thesis, which we will perform later.  
 
6. Conclusion 
The research project provides evidence that diabetes management in Bangladesh is 
suboptimal even under best clinical settings, which might be similar in many developing 
countries. We demonstrate the effectiveness of an innovative SMS model in addition to the 
standard of care management of T2D in Bangladesh. Automated mobile phone SMS represent 
a scalable and likely low-cost method to improve glycemic control for patients with T2D in 
Bangladesh and similar developing countries. The majority of our participants expressed 
willingness to receive diabetes-related SMS and pay a modest amount for such service, which 
seems reasonable compared with the current expenditure for physician fees. Considering the 
huge number of diabetes patients and the low mobile phone rates in Bangladesh, a self-
sustained business model for basic mHealth services for chronic diseases is therefore feasible 
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in this and potentially other low-income countries. As diabetes is a costly condition, 
prevention and optimum management of diabetes should be a priority for all stakeholders. 
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Annex-4. Post-hoc subgroup analysis of the SMS intervention trial 
   
Figure. Post-hoc subgroup analysis of the HbA1c difference between the intervention and the 
control group 
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